User: Guest  Login
Title:

Posaconazole liquid vs tablet formulation in lung transplant recipients.

Document type:
Journal Article; Article
Author(s):
Stelzer, D; Weber, A; Ihle, F; Matthes, S; Ceelen, F; Zimmermann, G; Kneidinger, N; Schramm, R; Winter, H; Zoller, M; Vogeser, M; Behr, J; Neurohr, C
Abstract:
Posaconazole is an extended-spectrum triazole antifungal used in the treatment and prophylaxis of Aspergillus infections. It is available as oral suspension (POS-Liq) and delayed-release tablets (POS-Tab). The aim of this longitudinal, retrospective study was to compare the clinical effectiveness, toxicity and pharmacokinetics of POS-Liq vs POS-Tab in lung transplant recipients (LTx-recipients), who were treated with both formulations subsequently. Twenty-four consecutive LTx-recipients with 191...     »
Journal title abbreviation:
Mycoses
Year:
2018
Journal volume:
61
Journal issue:
3
Pages contribution:
186-194
Fulltext / DOI:
doi:10.1111/myc.12724
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/29110351
Print-ISSN:
0933-7407
TUM Institution:
I. Medizinische Klinik und Poliklinik (Kardiologie)
 BibTeX